Balyasny Asset Management LLC Sight Sciences, Inc. Transaction History

Balyasny Asset Management LLC

  • $54.8 Billion
  • Q1 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
BUY
$1.29 - $5.86 $29,204 - $132,664
22,639 New
22,639 $116,000
Q2 2022

Aug 15, 2022
BUY
$6.61 - $11.99 $1.1 Million - $1.99 Million
165,935 New
165,935 $1.49 Million
Q1 2022

May 16, 2022
SELL
$11.56 - $17.9 $3.69 Million - $5.71 Million
-319,235 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$17.36 - $27.36 $3.55 Million - $5.59 Million
204,334 Added 177.83%
319,235 $5.61 Million
Q3 2021

Nov 15, 2021
BUY
$22.34 - $39.1 $2.57 Million - $4.49 Million
114,901 New
114,901 $2.61 Million

Others Institutions Holding SGHT

# of Institutions
69
Shares Held
21.1M
Call Options Held
33.2K
Put Options Held
27.7K
View Full List

About Sight Sciences, Inc.

SGHT Quotes by TradingView
  • Ticker SGHT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,826,200
  • Market Cap $296M
  • Description
  • Sight Sciences, Inc., an ophthalmic medical device company, engages in the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases. The company's products include OMNI Surgical System, a therapeutic device used by ophthalmic surgeons to reduce intraocular pressure in adult glaucoma patients; a...
More about SGHT
Track This Portfolio

Track Balyasny Asset Management LLC Portfolio

Follow Balyasny Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email